Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Euromedis Groupe specializes in the distribution of medical supplies and equipment across France and other European markets. The company differentiates itself through a strong logistics network and a diverse product portfolio that includes surgical instruments, consumables, and hospital equipment.
Euromedis generates revenue primarily through the sale of medical supplies and equipment to hospitals and clinics. Its competitive advantages include a well-established distribution network, strong supplier relationships, and a focus on customer service, allowing for premium pricing on specialized products.
Changes in healthcare spending in France and Europe
Regulatory changes affecting medical supply distribution
Supply chain disruptions impacting product availability
Market share gains from competitors
Regulatory changes in the healthcare sector
Technological disruption in medical supply distribution
Emergence of new competitors in the medical supply space
Price competition from larger distributors
Low net margin of -0.3% indicating potential liquidity issues
Dependence on supplier credit terms
moderate - The company's performance is somewhat linked to GDP growth and healthcare spending, which can fluctuate with economic conditions.
Interest rates affect the company's financing costs for inventory and logistics, potentially impacting margins and valuation multiples.
minimal - Euromedis operates with a manageable debt-to-equity ratio of 0.37, indicating limited reliance on credit.
value - The company's low valuation metrics (P/S of 0.4x) may attract value investors looking for turnaround opportunities.
moderate - Historical volatility is expected to be moderate given the stable nature of healthcare demand.
